Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug Tourism
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3R01DA049644-01A1S1
Grant search
Key facts
Disease
COVID-19Start & end year
20202025Known Financial Commitments (USD)
$5,429,240Funder
National Institutes of Health (NIH)Principal Investigator
STEFFANIE A STRATHDEEResearch Location
United States of AmericaLead Research Institution
UNIVERSITY OF CALIFORNIA-SAN DIEGOResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease transmission dynamics
Special Interest Tags
Data Management and Data Sharing
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Drug users
Occupations of Interest
Unspecified
Abstract
To respond to the burgeoning SARSCoV-2 epidemic, we propose to leverage the infrastructureof a new binational cohort of 600 people who inject drugs (PWID), as well as additional UCSDinvestigators who have expertise in analysis of social networks, microbiome, and geneticsequencing data to address the proposed aims:Aim 1. To determine the prevalence and correlates of subclinical and symptomatic SARSCoV-2infection among PWID within the SD/TJ border region.Aim 2. To determine the prevalence and correlates of SARSCoV-2 shedding in nasal secretionsand fecal specimens among PWID.Aim 3. To determine network features associated with cross-border transmission of subclinicalSARSCoV-2 infection among PWID.Aim 4: To use molecular epidemiology to determine the global migration of SARSCoV-2 betweenPWID in San Diego and Tijuana and factors associated with local and global dispersal.We will use social network surveys, microbiome analysis and full length SARSCoV-2 sequencingto characterize PWIDs' social network determinants of SARSCoV-2 infection, the influence of themicrobiome on shedding, and the viral genetic migrations within SD, TJ and beyond. Accurateestimates of subclinical infection of SARSCoV-2 and its risk factors are needed to informprevention, treatment, and public policy, especially in a cross-border context where borderclosures have already been implemented as a costly measure to curb transmission.